Delivery Order SPE2DB20D9127-SPE2DB23FPQS0

Award Date 5/30/23
Potential Completion Date 5/31/23
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $19,157.04 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 4,559,465,122 units of the prescription drug Nexavar 200 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC covers a comprehensive range of branded and generic prescription...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $56,298.24 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 120 tablets of the prescription drug Nexavar 200 mg, with a period of performance through September 8, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to...
The Defense Logistics Agency awarded a firm-fixed-price delivery order contract worth $28,149.12 to DMS Pharmaceutical Group Inc., a woman-owned small business organization located in Park Ridge, Illinois. The contract is for the delivery of Nexavar 200 mg tablets in quantities of 120 per bottle. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, number 4600082013, held by DMS Pharmaceutical Group with the Defense Logistics Agency. The IDV has a potential total...
This is a firm fixed-price delivery order (SPE2DB23FPQB3) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $9,578.52 and has a completion date of February 28, 2023. The award is for the delivery of Nexavar 200 mg tablets. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,383.04, is for the delivery of 120 tablets of the prescription drug Nexavar (sorafenib) 200 mg. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 120 tablets of the prescription drug Nexavar 200 mg, with a total ceiling value of $9,383.04 and a period of performance through September 5, 2023. The award is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a...
This federal contract award, valued at $13,781.49, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 120 units of the prescription drug Nexavar 200 mg tablet. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
This award is a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Nexavar 200 mg tablets. The order is placed under a $499,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) for a wide range of pharmaceutical products to support military healthcare facilities. The delivery order has a ceiling value of $9,578.52 and an ultimate completion date of July 26, 2022. This award is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $28,149.12 firm-fixed-price contract is for the delivery of 4,563,964 units of the pharmaceutical drug Nexavar 200 mg tablet in 120-count bottles. The contract has a period of performance through March 13, 2024. DMS Pharmaceutical Group holds a separate indefinite delivery contract, valued at up to $4,999,999, with DLA for a broad range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,781.49, is for the delivery of 4554629194 NEXAVAR 200 MG TABLET 120S, a prescription drug product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program....
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB23FPQS0
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,578.52, is for the delivery of Nexavar 200 mg tablets.

DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The current delivery order is not associated with any set-aside designation.

Generated 2/27/25, 11:20 AM